Results 21 to 30 of about 243,161 (291)

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B

open access: yesJournal of Blood Medicine, 2023
Katsuyuki Fukutake,1,2 Kanae Togo,3 Linghua Xu,3 Leona E Markson,4 José Maria Jimenez Alvir,5 Ian Winburn,6 Toshiyuki Karumori3 1Laboratory Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan; 2Department of Blood Coagulation Diseases, Ogikubo ...
Fukutake K   +6 more
doaj  

ERGONOMICS IN DRUG LABELING

open access: yesErgodesign & HCI, 2015
This article presents the study that aimed to analyze the visual ergonomic standards related to the drugs labels, especially the guidelines that point to aspects of readability. It started from the problematic that sought to understand whether the issues
Arina Blum   +2 more
doaj   +1 more source

Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA

open access: yesClinical and Translational Science, 2022
Clinical pharmacology is an integral discipline supporting the development, regulatory evaluation, and clinical use of drugs for the treatment of both common and rare diseases.
Julie Hsieh   +4 more
doaj   +1 more source

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021

open access: yesPharmaceutics, 2022
Understanding possible follow-up actions on in vitro findings helps determine the necessity of labeling for drug interactions. We analyzed information for in vitro findings on transporter-mediated interactions of drugs approved by the U.S.
Kyeong-Ryoon Lee   +4 more
doaj   +1 more source

A Comparative Study of Drug Package Inserts of High Selling Cardiac Drugs against the Drug Regulations of Iranian Food and Drug Administration [PDF]

open access: yesTaṣvīr-i salāmat, 2019
Background and Objectives: The Drug Package Insert (PI) is a written information provided by drug manufacturers to deliver essential information for the consumer.
Sedigheh Mirzadeh Qasabeh   +1 more
doaj  

Linking structure and function of the asialoglycoprotein receptor H1-CRD using site-directed mutagenesis and isotope labeling [PDF]

open access: yes, 2007
The asialoglycoprotein receptor (ASGP-R) is a C-type lectin, abundantly expressed on hepatocytes. It mediates the clearance of desialylated glycoproteins carrying terminal galactose (Gal) or N-acetyl-galactosamine (GalNAc) residues through endocytosis ...
Johansson, Anna Karin
core   +1 more source

Current practices in organization of anesthesia drug tray

open access: yesAsian Journal of Medical Sciences, 2022
Background: The risk of medication error is high in the operating room, since the anesthesiologist prepares, stores, and administers the medication. Poor labeling practices and cluttered drug trays increase the risk of syringe swap and medication error ...
Sowmya Jois   +4 more
doaj   +1 more source

An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression [PDF]

open access: yes, 2021
Objectives: To determine the differences in information between prescribing guidelines and drug labeling, as well as to compare the approval of psychotropic medicines for major depression in pediatric patients ("pediatric depression") across countries ...
Taylor, David   +4 more
core   +1 more source

GPCR structural characterization by NMR spectroscopy in solution

open access: yesActa Biochimica et Biophysica Sinica, 2022
In the human proteome, 826 G-protein-coupled receptors (GPCRs) interact with extracellular stimuli to initiate cascades of intracellular signaling. Determining conformational dynamics and intermolecular interactions are key to understand GPCR function as
Yang Lingyun   +2 more
doaj   +1 more source

Isotopics – Isotopic labeling for Drug Innovation - H2020

open access: yes, 2017
International audienceISOTOPICS (H2020 - Marie Sklodowska-Curie Actions - Innovative Training Network; grant number 675071) combines researchers and industry in an innovative effort to de-risk drug development, create new tools for medicine and train ...
Christophe Dugave   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy